ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III
June 25, 2021AGC Biologics will manufacture the clinical trial materials at its site in Copenhagen to support clinical testing and launch readiness. -
Chemomab Receives EU Orphan Drug Designation for Primary Sclerosing Cholangitis Treatment
August 27, 2020Chemomab announces the European Commission (EC) has granted Orphan Drug Designation (ODD) to its lead drug candidate CM-101 for the treatment of patients with Primary Sclerosing Cholangitis (PSC) ... -
ChemomAb Doses First Patient in Phase 1b Clinical trial of CM-101
January 11, 2019ChemomAb announced dosing of the first patient in a Phase 1b repeated dose clinical trial with CM-101 in non-alcoholic fatty liver disease (NAFLD) patients....
Pharma Sources Insight January 2025
